Sentences with phrase «gynecologic cancer at»
Every year, 10,000 U.S. women are diagnosed with cervical cancer, and 3,600 die from the disease, according to Debbie Saslow, PhD, director of breast and gynecologic cancer at the American Cancer Society in Atlanta.
http://www.health.com/ Not exact matches
Today's guidance, written by a group of cervical cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.&cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidagynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical GuidaGynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.&Cancer Screening: Interim Clinical Guidance.»
«Estimating from various studies that looked at increasing BMI and endometrial cancer risk, a woman with a Body Mass Index (BMI) of 40 would have approximately eight times greater risk of endometrial cancer than someone with a BMI of 25,» said first author Kristy Ward, MD, the senior gynecologic oncology fellow in the Department of Reproductive Medicine at UC San Diego School of Medicine.
The combination of drugs appeared less toxic than standard chemotherapy, were relatively inexpensive and should be clinically evaluated, said Dwayne G. Stupack, PhD, the study's senior author and associate professor in the dDivision of Gynecologic Oncology at Moores Cancer Center.
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.
The trial was run by Professor Bradley J. Monk MD who directs the Division of Gynecologic Oncology at the University of Arizona Cancer Center at St. Joseph's in Phoenix and sponsored by Amgen.
«This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author ongynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author onGynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.
Our findings suggest that abstinence from regular physical activity is associated with increased odds of cervical cancer,» says J. Brian Szender, MD, MPH, lead author of the study and a fellow in the Department of Gynecologic Oncology at Roswell Park.
The preliminary findings were reported here at the Society of Gynecologic Oncology's Annual Meeting on Women's Cancer.
«Once the ovarian cancer becomes drug resistant we can not cure it,» says Rodriguez a gynecologic oncologist who provides treatment to ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New Jcancer becomes drug resistant we can not cure it,» says Rodriguez a gynecologic oncologist who provides treatment to ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New Jcancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New JCancer Institute of New Jersey.
«Now that we know exactly how changes in EMSY spur cancer cell growth, we can start to design therapies to specifically target that activity and hopefully stop it,» says senior author Douglas Levine, MD, director of the Division of Gynecologic Oncology at NYU Langone and its Perlmutter Cancer Ccancer cell growth, we can start to design therapies to specifically target that activity and hopefully stop it,» says senior author Douglas Levine, MD, director of the Division of Gynecologic Oncology at NYU Langone and its Perlmutter Cancer CCancer Center.
The four - year study involved 461 patients at 24 medical oncology clinics at Princess Margaret Cancer Centre, University Health Network (UHN) with advanced lung, gastrointestinal, genitourinary, breast and gynecologic cancers.
This study adds to the discussion about the role of this immunosurveillance in the risk of developing the common cancers among those with compromised immune systems,» adds first author Paul Mayor, MD, Fellow in the Department of Gynecologic Oncology at RPCI.
As part of an ongoing clinical trial at Rutgers Cancer Institute exploring rare and poor prognosis cancers, investigators sought to identify genomic alterations in 69 patients with gynecologic cancers that were not responding to standard care.
Our approach is to study more than one or two serial recurrences of the disease, adding information about the response to therapy and natural progress of ovarian cancer,» adds J. Brian Szender, MD, MS, senior author and a fellow in Gynecologic Oncology at RPCI.
The Medical College of Georgia at Augusta University is establishing the state of Georgia's first gynecologic oncology fellowship program to train physicians who diagnose and treat the cancers that...
Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New Orleans.
In my laboratory at NYU Langone, I focus on precision medicine, rare tumors, and early detection and prevention of gynecologic cancers.
«Based on a better understanding of its origins, our study suggests new strategies for the prevention and early detection of ovarian cancer,» senior study author Douglas A. Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells Medcancer,» senior study author Douglas A. Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells MedCancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells Medscape.
Topics and models to be covered include: nomenclature, basic mouse genetics, concepts of mouse model generation, approaches to working up mutant mice, role of pathologists at research institutions, systemic, hematopoietic, mammary, gynecologic, cutaneous, infectious and immune system pathology, embryology and cancer models.
Learn about your options for breast, gynecologic and colon cancer screening at Women & Infants Hospital.
At UT Southwestern Medical Center, our gynecologic cancer experts have unmatched expertise in treating patients with ovarian cancer.
«Visualizing how cancer cells interact with a tumor microenvironment that accurately reflects the complex biology of ovarian cancer should help us understand the mechanisms underlying metastatic progression as well as identify new therapeutics that can inhibit this process,» said clinical gynecologic oncologist Ernst Lengyel, MD, PhD, senior author of the study and a professor of obstetrics and gynecology at the University of Chicago.
It clearly shows that those who had maintenance [Avastin] had improved profession - free survival,» said Dr. Robert Morgan, co-director of the gynecologic oncology program at City of Hope Cancer Center in Duarte, Calif. «I think we have to wait for longer term outcomes before we make definite conclusions.
But surgeons today are getting more aggressive, seeking to remove all evidence of cancer from the get - go, says Barbara Goff, MD, director of gynecologic oncology at the University of Washington.
He is director of the division of gynecologic oncology at the Perlmutter Cancer Center, which is part of NYU Langone Health in New York City.
«Ovarian cancer is often diagnosed too late,» said Dr. David Fishman, director of the cancer center and gynecologic oncology at NewYork - Presbyterian / Queens.
«This study confirms that long - term use [of the pill] causes a profound reduction in the risk of ovarian and endometrial cancers,» said Dr. Stephen Rubin, chief of gynecologic oncology at Fox Chase Cancer Center in Philadelphia.
A Funny Thing Happened on the Way to the Gynecologic Oncology Unit at Memorial Sloan Kettering Cancer Center of New York.
I recently completed a medical assistant externship at DEF Hospital's Cancer Center, a world - class medical environment that included medical oncology, radiation oncology, diagnostic imaging, BMT and gynecologic oncology programs.